Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Neuroimage. Clinical|December 19, 2018
Regional gray matter changes and age predict individual treatment response in Parkinson's diseaseTommaso Ballarini, Karsten Mueller, Franziska Albrecht, et al.
Neuropsychiatric Disease and Treatment|September 13, 2016
Diffusion tensor imaging in the characterization of multiple system atrophyAaron Michael Rulseh, Jiri Keller, Jan Rusz, et al.
Cerebellum (London, England)|October 10, 2018
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson's DiseaseKarsten Mueller, Robert Jech, Tommaso Ballarini, et al.
European Radiology|June 13, 2012
Quantitative MR imaging and spectroscopy of brain tumours: a step forward?Dita Wagnerova, Vit Herynek, Alberto Malucelli, et al.
Neuroimage. Clinical|July 24, 2018
Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's diseaseKarsten Mueller, Robert Jech, Filip Růžička, et al.
Brain Communications|September 21, 2020
Differential effects of deep brain stimulation and levodopa on brain activity in Parkinson's diseaseKarsten Mueller, Dušan Urgošík, Tommaso Ballarini, et al.
Neuroimage. Clinical|April 10, 2023
Improving fMRI in Parkinson's disease by accounting for brain region-specific activity patternsRenzo Torrecuso, Karsten Mueller, Štefan Holiga, et al.
Pediatric Radiology|May 5, 2021
Safety and diagnostic efficacy of gadoteridol for magnetic resonance imaging of the brain and spine in children 2 years of age and youngerChetan C Shah, Maria Vittoria Spampinato, Hemant A Parmar, et al.
BMC Medical Physics|January 10, 2009
Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields)Eilon D Kirson, Rosa S Schneiderman, Vladimír Dbalý, et al.
Nanoscale Advances|September 22, 2022
Formation of gadolinium-ferritin from clinical magnetic resonance contrast agentsJitka Neburkova, Aaron M Rulseh, Shery L Y Chang, et al.
Pageof 8